Quantitative protein and fat metabolism in bull calves treated with beta-adrenergic agonist.
Protein and energy utilization and quantitative retention of protein, fat and energy was investigated with 12 Red Danish bulls during two subsequent 6 weeks trials (Sections A and B) at a mean live weight of 195 and 335 kg respectively. Treatments were control (Group 1) and beta-agonist (L-644,969) treated animals (Group 2 and 3). Beta-agonist supplementation was 5 and 10 mg/d in Group 2 and 3 respectively in Section A and 10 and 20 mg/d in Section B. Measurements were performed by means of nitrogen and carbon balances and with use of indirect calorimetry. In each section the mean intake of dry matter, metabolizable energy and digestible protein was of the same magnitude for all groups. The beta-agonist had no significant effect on protein digestibility and metabolizability of energy, but daily live weight gain was significantly higher in the treated bulls. The utilization of digested protein was strongly influenced by treatment, with the highest values for Group 2 in both sections. The protein retention increased with 25% in Group 2, with the highest increment of 113 g/d in Section B. The fat retention decreased in treated animals, most pronounced in Group 3, where the reduction was about 50% with a mean decrease of 145 g/d in Section B. The total energy retention was not different between control animals and Group 2 in both sections, but there was a shift in energy retention from fat to protein. The higher levels of beta-agonist used in Group 3 generated the same increase in protein retention, but fat retention was markedly lower and consequently the total energy retention was reduced.
Chwalibog
A
A
Department of Animal Science and Animal Health, Royal Veterinary and Agricultural University, Copenhagen, Denmark.
Jensen
K
K
Thorbek
G
G
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D002153:Calorimetry, Indirect / Q000662:veterinary; D002417:Cattle / Q000378:metabolism* / Q000502:physiology; D004041:Dietary Fats / Q000378:metabolism*; D004044:Dietary Proteins / Q000378:metabolism*; D004435:Eating / Q000187:drug effects / Q000502:physiology; D004734:Energy Metabolism / Q000502:physiology; D008297:Male; D011725:Pyridines / Q000494:pharmacology*; D015430:Weight Gain / Q000187:drug effects / Q000502:physiology
D000318:Adrenergic beta-Agonists; D004041:Dietary Fats; D004044:Dietary Proteins; D011725:Pyridines; C061557:6-amino-alpha-(((1-methyl-3-phenylpropyl)amino)methyl)-3-pyridine methanol